Company Filing History:
Years Active: 1979-1997
Title: Innovations of James M Greene
Introduction
James M Greene is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel polymorphs of dirithromycin. With a total of 7 patents to his name, Greene's work has had a substantial impact on drug formulation and delivery.
Latest Patents
One of Greene's latest patents is focused on the process for preparing crystal forms and solvates of dirithromycin. This invention provides Form II dirithromycin, a novel polymorph that enhances the efficiency of drug preparation and isolation. The patent also discloses various solvates of dirithromycin, including those with acetone, 1-butanol, 1-propanol, and 2-propanol. These advancements allow for improved methods of obtaining Form II dirithromycin from both solvated and non-solvated forms. Additionally, Greene's work includes the development of an improved tablet formulation containing Form II dirithromycin as the active ingredient.
Career Highlights
Greene is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its innovative research and development. His role at Eli Lilly has allowed him to contribute to groundbreaking advancements in drug formulation and delivery systems.
Collaborations
Throughout his career, Greene has collaborated with talented individuals such as Holly M Hankins and Gregory Alan Stephenson. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
James M Greene's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of effective drug formulations, showcasing the importance of innovation in healthcare.